Testing effectiveness (Phase 2)Ended earlyNCT04240886
What this trial is testing
Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds
Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 21